Get the Stockscreener App
78.28
1.08%
0.84
After Hours:
78.34
0.06
+0.08%
Disc Medicine Inc stock is traded at $78.28, with a volume of 305.51K.
It is up +1.08% in the last 24 hours and up +2.21% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
See More
Previous Close:
$77.44
Open:
$77.44
24h Volume:
305.51K
Relative Volume:
0.55
Market Cap:
$2.99B
Revenue:
-
Net Income/Loss:
$-241.60M
P/E Ratio:
-11.83
EPS:
-6.6167
Net Cash Flow:
$-201.34M
1W Performance:
+2.58%
1M Performance:
+2.21%
6M Performance:
+4.72%
1Y Performance:
+34.90%
1-Day Range:
$75.79
$78.78
1-Week Range:
$75.79
$80.99
52-Week Range:
$40.00
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
78.28 | 2.85B | 0 | -241.60M | -201.34M | -6.6167 |
VRTX
Vertex Pharmaceuticals Inc
|
523.91 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
808.05 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
866.11 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.97 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
359.00 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Resumed | Stifel | Buy |
| Jul-21-25 | Initiated | Truist | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jun-11-25 | Resumed | Raymond James | Strong Buy |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-23-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jun-07-23 | Initiated | H.C. Wainwright | Buy |
| May-17-23 | Initiated | Raymond James | Outperform |
| Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-21-23 | Initiated | Stifel | Buy |
| Apr-20-23 | Initiated | Morgan Stanley | Overweight |
| Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - Morningstar
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
TradingKey - TradingKey
Disc Medicine Inc (IRON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Disc Medicine Inc (IRON) Institutional Confidence - TradingKey
Disc Medicine Inc (IRON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRON|Disc Medicine Inc|Price:74.120|Chg%:-1.740 - TradingKey
Disc Medicine Inc (IRON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRON|Disc Medicine Inc|Price:74.640|Chg%:+0.520 - TradingKey
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verra Mobility Corporation Investors with Losses to Secure Counsel Before Important August 4 Deadline in Securities Class Action - GlobeNewswire Inc.
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Price to earnings forward of Disc Medicine, Inc. – NASDAQ:IRON - TradingView
Going Deeper On Disc Medicine (NASDAQ:IRON) - Seeking Alpha
Disc Medicine, Inc. (IRON) Stock Analysis: Biotech Innovator With 36.52% Upside Potential - DirectorsTalk Interviews
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - ACCESS Newswire
(IRON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Truist Securities Initiates Coverage of Disc Medicine (IRON) with Buy Recommendation - MSN
Lobbying Update: $50,000 of DISC MEDICINE lobbying was just disclosed - Quiver Quantitative
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - ACCESS Newswire
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record
Cantor Fitzgerald reiterates Disc Medicine stock rating on pipeline catalysts - Investing.com
Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing - Moomoo
Disc Medicine CEO John Quisel sells $2.47m in shares By Investing.com - Investing.com India
Form 4 Disc Medicine Inc For: 14 July By Investing.com - Investing.com South Africa
Disc Medicine CEO John Quisel sells $2.47m in shares - Investing.com
Disc Medicine (NASDAQ: IRON) CEO exercises options and sells 33,000 shares - Stock Titan
Form 144 Disc Medicine For: 13 July By Investing.com - Investing.com South Africa
Ironwood Pharmaceuticals (NASDAQ: IRON) plans 33,000-share sale via options exercise - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
Price to earnings forward of Disc Medicine, Inc. – BOATS:IRON - TradingView
Disc Medicine Inc. (IRON) Q1 2026 Earnings: Clinical Progress Amidst Market SkepticismRevenue Inflection Point - dars.gov.et
Disc Medicine COO Jonathan Yu sells $8,250 in stock By Investing.com - Investing.com Nigeria
Form 4 Disc Medicine Inc For: 9 July By Investing.com - Investing.com Canada
Disc Medicine COO Jonathan Yu sells $8,250 in stock - Investing.com
Disc Medicine (IRON) COO trades 100 shares after option exercise under 10b5-1 plan - Stock Titan
Why Disc Medicine's Extended Hercules Credit Access Could Reshape IRON's Funding Flexibility Narrative - simplywall.st
Broker files Form 144 for 10,000 IRON shares (IRON) — option exercise sale - Stock Titan
IRON Q1 2026 Earnings: Narrower-than-expected loss highlights cost control amid clinical progressLong-Term Guidance - dars.gov.et
Bronstein, Gewirtz & Grossman, LLC Is Investigating Disc Medicine, Inc. (IRON) And Encourages Investors to Connect - The National Law Review
Disc Medicine (IRON) Could Be 67% Undervalued On Its $30 Million Loan Reset - Sahm
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Disc Medicine Inc Stock (IRON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Khara Rahul | Chief Legal Officer |
Aug 06 '26 |
Sale |
80.00 |
5,000 |
400,000 |
52,324 |
0.82%
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):